$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
乙肝病毒致癌机制
2025-10-19 11:44:20
Check Details
乙肝免疫耐受期接受抗病毒治疗可预防肝癌
2025-10-19 11:44:20
Check Details
乙肝是导致肝癌的重要杀手
2025-10-19 11:44:20
Check Details
乙肝治疗不规范,诱发肝癌
2025-10-19 11:44:20
Check Details
Mycludex B与替诺福韦有效治疗丁肝乙肝合并感染
2025-10-19 11:44:20
Check Details
85%的肝癌患者由乙肝转化
2025-10-19 11:44:20
Check Details
用TNF拮抗剂治疗的患者需检查乙肝再激活
2025-10-19 11:44:20
Check Details
乙型肝炎治疗期间转氨酶正常降低肝脏事件风险
2025-10-19 11:44:20
Check Details
替诺福韦治疗乙肝肝硬化安全有效
2025-10-19 11:44:20
Check Details
慢性乙型肝炎患者服用替诺福韦二代的长期安全性更新数据
2025-10-19 11:44:20
Check Details
赶快阻止这个无声的杀手——乙型肝炎
2025-10-19 11:44:20
Check Details
乙肝抗病毒治疗用药替诺福韦
2025-10-19 11:44:20
Check Details
1
2
...
101
102
103
104
105
106
107
...
505
506
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
2
A Precision FGFR Inhibitor for Cholangiocarcinoma
3
Best time to take Luqu Bopa (Wenkedake) and precautions
4
Is defibrotide included in medical insurance?
5
When was defibrinoside launched on the market?
6
Will defibrination be reimbursed by medical insurance?
7
What conditions is defibrinoside suitable for treating?
8
What is the therapeutic effect of defibrotide?
9
How should defibrinoside be used?
10
What is the effect of defibrotide?
11
Defibrinoside Detailed Instructions
12
What is the effect of defibrination?